Profs. Drs. R I Gregory, Camargo FD and their co-workers from Boston Children’s Hospital, MA, USA; Department of Biological Chemistry and Molecular Pharmacology and Department of Pediatrics, Harvard Medical School, Boston, MA, USA; and Harvard Stem Cell Institute, Boston, MA, USA had reported in the prestigious journal Cell (Feb 27, 2014) that “Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer”
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Anti-miRNA-based therapeutics for human cancer: miRNA-141 suppresses widespread miRNA biogenesis via down regulation of its target gene. This data may suggest that miRNA-141 could function as an oncomiR by suppressing the network of tumor suppressor miRNAs.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, L, Anti-miRNA-based therapeutics for human cancer: miRNA-141 suppresses widespread miRNA biogenesis via down regulation of its target gene, 14/May/2014, 9.33 am
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation